Logo
C

Checkmab

8 employees

Checkmab aims to develop monoclonal antibodies against Treg cells in diseased tissues as immunotherapies against autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Product Research

Date founded

2018

FAQ